Clinical Profile, Comorbidities, and Outcome of the Unvaccinated and Hospitalized for COVID-19 in Northern Brazil: Retrospective Cohort

Author:

Lúcia da Silva Ferreira Ana,Sardinha Daniele Melo,Cristina Viana de Moraes Daiane,Raimunda Rodrigues de Oliveira Maria,Carolina Frazão Viana Mayara,Cristina Oliveira Andrade Natasha,de Nazaré Soares Tamires,José de Paula Souza e Guimarães Ricardo,Nepomuceno Gondim Costa Lima Luana,Valéria Batista Lima Karla

Abstract

AbstractOver the course of the pandemic, COVID-19 affected health, the economy and quality of life in Brazil. The worst years for the country were the first and second. There were delays in vaccine purchases for political reasons at the time. The northern region of the country had a higher mortality rate compared to other regions, associated with local vulnerabilities and fragility of surveillance due to geographic and population characteristics. This study aims to investigate the clinical profile, comorbidities, and outcome of unvaccinated people hospitalized for COVID-19 in the state of Pará in 2022. Retrospective cohort epidemiological study, with data from the national epidemiological surveillance of acute and severe respiratory syndromes. Cases reported in 2022 with vaccinated yes or no field and completed doses were included. Only closed cases cure or death were included. We performed a chi-square test on categorical variables and a Mann-Whitney test on numerical variables. We compared vaccinated VS non-vaccinated; we performed the Odds Ratio in the significant variables. We used the SPSS 20.0 software. The study worked with 2,634 cases of COVID-19 hospitalized in the study period, confirmed by RT-PCR (851/32.30%) and (1,784/67.70%) rapid antigen test. The lethality was (778/29.53%), and those vaccinated with two doses were (1,473/55.90%) and those unvaccinated with no dose (1,162/44.10%). Death represents p-<0.001 (HR 1.306 - CI 1.124/1.517) higher risk of the event occurring in the unvaccinated cases, followed by male sex p-0.004 (HR 1.188 - CI 1.058/1.334).. The first cohort in Brazil and in the north of the country to evaluate the clinical profile, comorbidities, and outcome of COVID-19 in hospitalized patients in this Amazon region, which is a region characterized by local vulnerability factors unique to the other regions of Brazil, showed that the unvaccinated were males, younger, with fewer comorbidities, and that they were associated the deaths.

Publisher

Cold Spring Harbor Laboratory

Reference39 articles.

1. Brasil M da S. Conselho Nacional de Saúde - CNS denuncia internacionalmente governo brasileiro por violação de direitos humanos durante pandemia. ConselhoSaudeGovBr 2021. http://conselho.saude.gov.br/ultimas-noticias-cns/2071-cns-denuncia-internacionalmente-governo-brasileiro-por-violacao-de-direitos-humanos-durante-pandemia (accessed January 23, 2023).

2. WHO WHO. Brazil: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Covid-19WhoInt 2023. https://covid19.who.int/region/amro/country/br (accessed March 26, 2023).

3. Ministério da Saúde (BR). Guia de vigilância epidemiológica : emergência de saúde pública de importância nacional pela doença pelo coronavrus 2019 – covid-19. Braslia - DF: Secretaria de Vigilância em Saúde - Ministério da Saúde do Brasil; 2022.

4. El Pas . Ritmo lento na vacinação contra a covid-19 no Brasil favorece novas cepas do vrus | Atualidade | EL PAS Brasil. El Pais Bras 2021. https://brasil.elpais.com/brasil/2021-02-03/ritmo-lento-na-vacinacao-contra-a-covid-19-no-brasil-favorece-novas-cepas-do-virus.html (accessed January 23, 2023).

5. Fiocruz FOC . Brasil celebra um ano da vacina contra a Covid-19. PortalFiocruz 2022. https://portal.fiocruz.br/noticia/brasil-celebra-um-ano-da-vacina-contra-covid-19 (accessed January 23, 2023).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3